Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-12-04
2007-12-04
Zara, Jane (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C435S091100, C435S375000, C435S455000, C536S023100, C536S024300, C536S024500
Reexamination Certificate
active
11113378
ABSTRACT:
The invention provides improved nucleic acid ligands that inhibit coagulation and improved modulators of the nucleic acids to provide ideal modulators of coagulation. These improved nucleic acids and modulators are particularly useful for inhibiting coagulation in a host undergoing a therapeutic regime such as surgery or coronary artery bypass.
REFERENCES:
patent: 5245022 (1993-09-01), Weis et al.
patent: 5270163 (1993-12-01), Gold et al.
patent: 5475096 (1995-12-01), Gold et al.
patent: 5476766 (1995-12-01), Gold et al.
patent: 5532130 (1996-07-01), Alul
patent: 5534408 (1996-07-01), Green et al.
patent: 5543293 (1996-08-01), Gold et al.
patent: 5552391 (1996-09-01), Coutts et al.
patent: 5582981 (1996-12-01), Toole et al.
patent: 5594121 (1997-01-01), Froehler et al.
patent: 5595877 (1997-01-01), Gold et al.
patent: 5606047 (1997-02-01), Coutts et al.
patent: 5645985 (1997-07-01), Froehler et al.
patent: 5648214 (1997-07-01), Nieuwlandt et al.
patent: 5660985 (1997-08-01), Pieken et al.
patent: 5670633 (1997-09-01), Cook et al.
patent: 5670637 (1997-09-01), Gold et al.
patent: 5681702 (1997-10-01), Collins et al.
patent: 5686242 (1997-11-01), Bruice et al.
patent: 5696249 (1997-12-01), Gold et al.
patent: 5723323 (1998-03-01), Kauffman et al.
patent: 5750729 (1998-05-01), Alexander et al.
patent: 5756291 (1998-05-01), Griffin et al.
patent: 5760202 (1998-06-01), Cook et al.
patent: 5780221 (1998-07-01), Schumacher et al.
patent: 5780449 (1998-07-01), Bracht et al.
patent: 5780610 (1998-07-01), Collins et al.
patent: 5792608 (1998-08-01), Swaminathan et al.
patent: 5792613 (1998-08-01), Schmidt et al.
patent: 5807718 (1998-09-01), Joyce et al.
patent: 5814476 (1998-09-01), Kauffman et al.
patent: 5817781 (1998-10-01), Swaminathan et al.
patent: 5817785 (1998-10-01), Gold et al.
patent: 5830653 (1998-11-01), Froehler et al.
patent: 5839443 (1998-11-01), Rose
patent: 5840867 (1998-11-01), Toole et al.
patent: 5843653 (1998-12-01), Gold et al.
patent: 5859221 (1999-01-01), Cook et al.
patent: 5861254 (1999-01-01), Schneider
patent: 5861501 (1999-01-01), Benseler
patent: 5872232 (1999-02-01), Cook et al.
patent: 5879917 (1999-03-01), Essigmann et al.
patent: 5882870 (1999-03-01), Nadeau
patent: 5882941 (1999-03-01), Essigmann et al.
patent: 5891689 (1999-04-01), Takle et al.
patent: 5935776 (1999-08-01), Green et al.
patent: 5958691 (1999-09-01), Pieken et al.
patent: 5989823 (1999-11-01), Jayasena et al.
patent: 6001820 (1999-12-01), Hirsh et al.
patent: 6004746 (1999-12-01), Brent
patent: 6005087 (1999-12-01), Cook et al.
patent: 6011020 (2000-01-01), Gold et al.
patent: 6051388 (2000-04-01), Bodenhamer
patent: 6054274 (2000-04-01), Sampson et al.
patent: 6060056 (2000-05-01), Coutts et al.
patent: 6083696 (2000-07-01), Biesecker et al.
patent: 6093555 (2000-07-01), Dudycz
patent: 6110462 (2000-08-01), Barbas et al.
patent: 6110721 (2000-08-01), Gibbs et al.
patent: 6110900 (2000-08-01), Gold et al.
patent: 6111095 (2000-08-01), Benseler et al.
patent: 6114038 (2000-09-01), Castro et al.
patent: 6117557 (2000-09-01), Massie, II et al.
patent: 6120997 (2000-09-01), Wong et al.
patent: 6127119 (2000-10-01), Stephens et al.
patent: 6127173 (2000-10-01), Eckstein et al.
patent: 6136545 (2000-10-01), Hoesel et al.
patent: 6147204 (2000-11-01), Gold et al.
patent: 6150461 (2000-11-01), Takei et al.
patent: 6153410 (2000-11-01), Arnold et al.
patent: 6163714 (2000-12-01), Stanley et al.
patent: 6171795 (2001-01-01), Korman et al.
patent: 6177263 (2001-01-01), Arnold et al.
patent: 6177555 (2001-01-01), Jayasena et al.
patent: 6180348 (2001-01-01), Li
patent: 6183967 (2001-02-01), Jayasena et al.
patent: 6222025 (2001-04-01), Cook et al.
patent: 6258601 (2001-07-01), Monia et al.
patent: 6315995 (2001-11-01), Pinsky
patent: 6316198 (2001-11-01), Skouv et al.
patent: 6316403 (2001-11-01), Pinsky
patent: 6331398 (2001-12-01), Gold et al.
patent: 6391300 (2002-05-01), Rose
patent: 6531584 (2003-03-01), Cook et al.
patent: 2003/0083294 (2003-05-01), Sullenger et al.
patent: 2003/0175703 (2003-09-01), Sullenger
patent: 0593901 (1994-04-01), None
patent: 1 026 243 (2000-08-01), None
patent: 11127864 (1999-05-01), None
patent: WO92/14842 (1992-09-01), None
patent: WO94/06811 (1994-03-01), None
patent: WO94/08050 (1994-04-01), None
patent: WO97/42317 (1997-11-01), None
patent: WO99/33971 (1999-07-01), None
patent: WO99/50462 (1999-10-01), None
patent: WO 00/20040 (2000-04-01), None
patent: WO 00/22114 (2000-04-01), None
patent: WO 00/24912 (2000-05-01), None
patent: WO 00/42063 (2000-07-01), None
patent: WO 00/42064 (2000-08-01), None
patent: WO 00/47774 (2000-08-01), None
patent: WO 02/26932 (2002-04-01), None
patent: WO 02/096926 (2002-12-01), None
patent: WO 03/093422 (2003-11-01), None
patent: WO 2004/011680 (2004-02-01), None
patent: WO 2004/014844 (2004-02-01), None
patent: WO 2004/047742 (2004-06-01), None
patent: WO 2004/050899 (2004-06-01), None
patent: WO 2005/010150 (2005-02-01), None
patent: WO 2005/014533 (2005-02-01), None
patent: WO 2005/052121 (2005-06-01), None
patent: WO 2005/084412 (2005-09-01), None
patent: WO 2005/111238 (2005-11-01), None
patent: WO 2006/029258 (2006-03-01), None
patent: WO 2006/033854 (2006-03-01), None
Hwang, S. et al., Proc. National Acad. Science (PNAS), vol. 96, No. 23, pp. 12,997-13,002 (1999).
Agrawal et al. Mol. Med. Today (2000) 6:72-81.
Aldaz-Caoll et al. Apical loop-internal loop interactions: a new RNA-RNA recognition motif identified through in vitro selection against RNA hairpins of the hepatitis C virus mRNA Biochemistry 41:5883-5893 (2002) (abst).
Biedenkapp, et al., Viral myb oncogene encodes a sequence-specific DNA-binding activity, Nature 335: 835-837 (1988).
Biesecket et al. Derivation of RNA aptamer inhibitors of human complement C5 Immunopharmacology 42:219-230 (1999) (abst).
Boiziau et al. DNA aptamers selected against the HIV-1 trans-activation responsive RNA element form RNA-DNA kissing complexes J Biol Chem 274:12730-12737 (1999).
Burke, et al. A novel axidophilic RNA motif that recognizes Coenzyme A Biochemistry, p. 4653-4663 (Nov. 25, 1997) (abst).
Callas et al. Comparative pharmacology of site directed antithrombin agents Implication in drug development Thrombosis and haemostasis (1995) 74:473-481(abst).
Charlton et al. IN vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase CHem. Biol. 4:809-816 (1997) (abst).
Collin et al. NMR characterization of a kissing complex formed between the TAR RNA element of HIV-1 and a DNA aptamer Nucl. Ac. Rsch. 28:3386-3391 (2000).
Darfeuille et al. RNA and N3′-P5′ kissing aptamers targeted to the trans-activation responsive (TAR) RNA of the human immunodeficiency virus-1 Nucs Nucl. Nuc. Ac. 20:441-449 (2001) (abst).
Duconge et al. Is closing “GA PAI” a rule for stable loop-loop RNA complexes! J. Biol. Chem 275:21287-21294 (2000).
Gal et al. Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function Eropean J. Biochem. 252:553-562 (1998) (abst).
Hwang et al. Inhibition of gene expression in human cells through small molecule -RNA interactions PNAS 96:12977 (1999).
Jen et al. (2000) Stem Cells 18:307-319.
Kinzler & Vogelstein, Whole genome PCR: application to the identificaiton of sequences bound by gene regulatory proteins, Nuc. Acids Rsch. 17: 3645 (1989).
LeClerc, et al. A three dimensional model of the Rev-binding element of HIV- a derived from analyses of apramers Nat. Struct. Biol. 1:293-300 (abst) (1994).
Leva et al. GnRH binding RNA and DNA Spiegelmers A novel approach toward GnRH antagonism Chemistry & Biology 8:351-359 (2002).
Li et al. A novel nucleotide based thrombin inhibitor inhibits clot bound thrombin and reduces arterial platelet thrombus formation Blood 83:677-682 (1994) (abst).
Oliphant, Brandl, Struhl, Defining the sequence specificity of DNA-binding proteins by selecting binding sites from random-sequence oligonucleotides: analysis of yeast GCN4 protein, Mol. Cell. Bio. 9: 2944-2949(1989).
Opalinska, et al. Nature Reviews Drug Discovery (2002) 1:503-514.
Padmanab
Bellows, Esq. Brent R.
King & Spalding LLP
Regado Biosciences, Inc.
Zara Jane
LandOfFree
Modulators of coagulation factors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of coagulation factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of coagulation factors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3893801